Imatinib
CAS 152459-95-5
In Stock
Imatinib
Cat. No. STUB-API-IMATINIBCAS 152459-95-5In Stock
Technical Data
Cat. No.STUB-API-IMATINIB
CAS152459-95-5
Mol. FormulaC29H31N7O
Mol. Weight493.615 g/mol
IUPAC4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
SMILESCC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
InChIInChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
InChI KeyKTUFNOKKBVMGRW-UHFFFAOYSA-N
Purity—
Description
Overview
Imatinib, sold under the brand names Gleevec and Glivec among others, is an oral chemotherapy medication used to treat cancer
Anant Labs manufacture and furnish high quality Imatinib impurities for global markets. Our Imatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Imatinib152459-95-5N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamideGlamox4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamideBKJ8M8G5HINSC-743414NSC-759854N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamideDTXSID3037125
